Stock Earnings

Question 1

¿Cuáles son los estados financieros clave de Lee's Pharmaceutical Holdings Ltd?

Accepted Answer

Según el último estado financiero (Form-10K), Lee's Pharmaceutical Holdings Ltd tiene un total de activos de $2,617, una ganancia neta profit de $93

Question 2

¿Cuáles son los ratios financieros clave para LPCUF?

Accepted Answer

El ratio corriente de Lee's Pharmaceutical Holdings Ltd es 2.7, el margen neto es 6.64, las ventas por acción son $2.37.

Question 3

¿Cómo se desglosan los ingresos de Lee's Pharmaceutical Holdings Ltd por segmento o geografía?

Accepted Answer

Lee's Pharmaceutical Holdings Ltd largest revenue segment is Proprietary and Generic Products, at a revenue of 585,758,000 in the most earnings release.For geography, China is the primary market for Lee's Pharmaceutical Holdings Ltd, at a revenue of 1,053,034,000.

Question 4

¿Es rentable Lee's Pharmaceutical Holdings Ltd?

Accepted Answer

yes, según los últimos estados financieros, Lee's Pharmaceutical Holdings Ltd tiene una ganancia neta profit de $93

Question 5

¿Tiene Lee's Pharmaceutical Holdings Ltd alguna deuda?

Accepted Answer

yes, Lee's Pharmaceutical Holdings Ltd tiene una deuda de 966

Question 6

¿Cuántas acciones en circulación tiene Lee's Pharmaceutical Holdings Ltd?

Accepted Answer

Lee's Pharmaceutical Holdings Ltd tiene un total de acciones en circulación de 588.83

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	1,436	1,399	1,053	1,233	1,266	1,216
Revenue Growth (YoY)	20%	33%	-15%	-3%	4%	0%
Cost of Revenue	673	646	501	462	459	435
Gross Profit	762	753	551	770	806	781
Selling, General & Admin	581	596	494	544	753	518
Research & Development	91	83	96	168	243	203
Operating Expenses	652	630	515	641	901	586
Other Non Operating Income (Expenses)	--	0	0	0	-1	-1
Pretax Income	97	98	30	67	1,969	134
Income Tax Expense	33	29	10	22	9	55
Net Income	97	93	16	51	1,987	129
Net Income Growth	54%	480.99%	-69%	-97%	1,440%	3%
Shares Outstanding (Diluted)	588.83	588.83	588.83	588.83	589.04	588.16
Shares Change (YoY)	0%	0%	0%	0%	0%	-1%
EPS (Diluted)	0.16	0.15	0.02	0.08	3.37	0.21
EPS Growth	55%	457%	-67%	-97%	1,434%	4%
Free Cash Flow	136	34	-49	69	-160	-139
Free Cash Flow Per Share	0.23	0.05	-0.08	0.11	-0.27	-0.23
Gross Margin	53.06%	53.82%	52.32%	62.44%	63.66%	64.22%
Operating Margin	7.66%	8.79%	3.41%	10.46%	-7.5%	15.95%
Profit Margin	6.75%	6.64%	1.51%	4.13%	156.95%	10.6%
Free Cash Flow Margin	9.47%	2.43%	-4.65%	5.59%	-12.63%	-11.43%
EBITDA	--	270	185	281	51	321
EBITDA Margin	--	19.29%	17.56%	22.78%	4.02%	26.39%
D&A For EBITDA	--	147	149	152	146	127
EBIT	110	123	36	129	-95	194
EBIT Margin	7.66%	8.79%	3.41%	10.46%	-7.5%	15.95%
Effective Tax Rate	34.02%	29.59%	33.33%	32.83%	0.45%	41.04%

Lee's Pharmaceutical Holdings Ltd (LPCUF) Price

LPCUF Stock Price Chart

LPCUF Income

Follow-Up Questions